ATC
KRYS icon

Argent Trust Co’s Krystal Biotech KRYS Stock Holding History

Argent Trust Co’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$326K Hold
1,261
– – 0.01% 585
2025
Q4 		$311K Sell
1,261
-46
-4% -$9.68K 0.01% 584
2025
Q3 		$231K Buy
+1,307
New +$196K 0.01% 640
2025
Q2 		– Sell
-1,692
Closed -$305K – 718
2025
Q1 		$305K Sell
1,692
-207
-11% -$34.8K 0.01% 551
2024
Q4 		$297K Hold
1,899
– – 0.01% 556
2024
Q3 		$346K Buy
+1,899
New +$366K 0.01% 510

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Argent Trust Co's KRYS Position: Q1 2026 in Review

Argent Trust Co held its Krystal Biotech (KRYS) position steady in Q1 2026 at 1,261 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #585.

Argent Trust Co first reported a position in KRYS in Q3 2024 and has held it in 6 quarters since. The position peaked at $346K in Q3 2024. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Argent Trust Co held 1,261 shares of Krystal Biotech worth $326K as of Q1 2026.
  • Argent Trust Co left its Krystal Biotech share count unchanged in Q1 2026.
  • Krystal Biotech made up 0.01% of Argent Trust Co's portfolio in Q1 2026, its #585 holding.
  • Argent Trust Co first reported a position in Krystal Biotech in Q3 2024 and has held it in 6 quarters since.
  • Argent Trust Co's Krystal Biotech position peaked at $346K in Q3 2024.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.